Comprehensive approaches to managing delirium in patients with advanced cancer

Jung Hun Kang; Seong Hoon Shin; Eduardo Bruera

doi:10.1016/j.ctrv.2012.08.001

Comprehensive approaches to managing delirium in patients with advanced cancer

Jung Hun Kang, Seong Hoon Shin, Eduardo Bruera

Research output: Contribution to journal › Review article › peer-review

30 Scopus citations

Abstract

Delirium is a frequently under-recognized complication in patients with advanced cancer. Uncontrolled delirium eventually leads to significant distress to patients and their families. However, delirium episodes can be reversed in half of these patients by eliminating precipitating factors and using appropriate interventions. The purpose of this narrative review is to discuss the most recent updates in the literature on the management of delirium in patients with advanced cancer. This article addresses the epidemiology, cause, pathophysiology, clinical characteristics, and assessment of delirium as well as various treatment options, including nonpharmacologic intervention and palliative sedation.

Original language	English (US)
Pages (from-to)	105-112
Number of pages	8
Journal	Cancer treatment reviews
Volume	39
Issue number	1
DOIs	https://doi.org/10.1016/j.ctrv.2012.08.001
State	Published - Feb 2013

Keywords

Advanced cancer
Delirium

ASJC Scopus subject areas

Oncology
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.ctrv.2012.08.001

Cite this

@article{741a5654228c414a999d14880789e0c5,

title = "Comprehensive approaches to managing delirium in patients with advanced cancer",

abstract = "Delirium is a frequently under-recognized complication in patients with advanced cancer. Uncontrolled delirium eventually leads to significant distress to patients and their families. However, delirium episodes can be reversed in half of these patients by eliminating precipitating factors and using appropriate interventions. The purpose of this narrative review is to discuss the most recent updates in the literature on the management of delirium in patients with advanced cancer. This article addresses the epidemiology, cause, pathophysiology, clinical characteristics, and assessment of delirium as well as various treatment options, including nonpharmacologic intervention and palliative sedation.",

keywords = "Advanced cancer, Delirium",

author = "Kang, {Jung Hun} and Shin, {Seong Hoon} and Eduardo Bruera",

note = "Funding Information: We appreciate Bryan Tutt in the Department of Scientific Publications at MD Anderson Cancer Center for valuable editorial assistance. This research is supported in part by the National Institutes of Health through MD Anderson{\textquoteright}s Cancer Center Support Grant, CA016672 . The sponsors have no involvement in the article design, collection of literature, interpretation of data, writing of the manuscript, or decision to submit the manuscript for publication.",

year = "2013",

month = feb,

doi = "10.1016/j.ctrv.2012.08.001",

language = "English (US)",

volume = "39",

pages = "105--112",

journal = "Cancer treatment reviews",

issn = "0305-7372",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Comprehensive approaches to managing delirium in patients with advanced cancer

AU - Kang, Jung Hun

AU - Shin, Seong Hoon

AU - Bruera, Eduardo

N1 - Funding Information: We appreciate Bryan Tutt in the Department of Scientific Publications at MD Anderson Cancer Center for valuable editorial assistance. This research is supported in part by the National Institutes of Health through MD Anderson’s Cancer Center Support Grant, CA016672 . The sponsors have no involvement in the article design, collection of literature, interpretation of data, writing of the manuscript, or decision to submit the manuscript for publication.

PY - 2013/2

Y1 - 2013/2

N2 - Delirium is a frequently under-recognized complication in patients with advanced cancer. Uncontrolled delirium eventually leads to significant distress to patients and their families. However, delirium episodes can be reversed in half of these patients by eliminating precipitating factors and using appropriate interventions. The purpose of this narrative review is to discuss the most recent updates in the literature on the management of delirium in patients with advanced cancer. This article addresses the epidemiology, cause, pathophysiology, clinical characteristics, and assessment of delirium as well as various treatment options, including nonpharmacologic intervention and palliative sedation.

AB - Delirium is a frequently under-recognized complication in patients with advanced cancer. Uncontrolled delirium eventually leads to significant distress to patients and their families. However, delirium episodes can be reversed in half of these patients by eliminating precipitating factors and using appropriate interventions. The purpose of this narrative review is to discuss the most recent updates in the literature on the management of delirium in patients with advanced cancer. This article addresses the epidemiology, cause, pathophysiology, clinical characteristics, and assessment of delirium as well as various treatment options, including nonpharmacologic intervention and palliative sedation.

KW - Advanced cancer

KW - Delirium

UR - http://www.scopus.com/inward/record.url?scp=84869087661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869087661&partnerID=8YFLogxK

U2 - 10.1016/j.ctrv.2012.08.001

DO - 10.1016/j.ctrv.2012.08.001

M3 - Review article

C2 - 22959227

AN - SCOPUS:84869087661

SN - 0305-7372

VL - 39

SP - 105

EP - 112

JO - Cancer treatment reviews

JF - Cancer treatment reviews

IS - 1

ER -

Comprehensive approaches to managing delirium in patients with advanced cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this